A Study Identifying Predictive Biomarkers for the Progression of Invasive Squamous Cell Carcinoma
About this study
The study will utilize both retrospective and prospective data collection from patients that already had a bronchoscopy and lung resection or will have a bronchoscopy and lung resection for squamous cell carcinoma. The investigators plan to prospectively collect 5 bronchoscopic biopsies, 3ml blood and one tumor and adjacent normal samples from 200 qualified patients who meet the study criteria.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- known or suspected squamous cell carcinoma of the lung
- able to provide consent
- could have already had a bronchoscopy or surgical resection with tissue saved at the Mayo Clinic Rochester
- will be undergoing a bronchoscopy and having a surgical resection at the Mayo Clinic Rochester
- unable to provide consent
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Dennis Wigle, M.D., Ph.D.
Closed for enrollment
Thoracic Surgery Research Unit